Clinical trialNCT05660746RecruitingPhase 2/PHASE3Interventional

Precise Infliximab Exposure and Pharmacodynamic Control

SponsorChildren's Hospital Medical Center, CincinnatiEnrollment180Crohn Disease

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Phillip Minar, MD,MS
Children's Hospital Medical Center, Cincinnati
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Children'S Hospital of Los Angeles
Los Angeles, California, United States
Mallory Chavannes, MD
Recruiting
Lucile Packard Children'S Hospital Stanford
Palo Alto, California, United States
Alka Goyal, MD
Recruiting
Rady Children'S Hospital San Diego
San Diego, California, United States
Laura Bauman, MD
Recruiting
Nemours Children'S Health System-Wilmington
Wilmington, Delaware, United States
Zarela Molle-Rios, MD
Recruiting
Nemours Children'S Health System-Jacksonville
Jacksonville, Florida, United States
Jill Dorsey, MD
Recruiting
Riley Hospital for Children
Indianapolis, Indiana, United States
Steven Steiner, MD
Recruiting
Cincinnati Children'S Hospital
Cincinnati, Ohio, United States
Phillip Minar, MD, MS
Recruiting
Cleveland Clinic Children'S Hospital
Cleveland, Ohio, United States
Jacob Kurowski, MD
Recruiting
Nationwide Children'S Hospital
Columbus, Ohio, United States
Brendan Boyle
Recruiting
Children'S Specialty Group
Norfolk, Virginia, United States
Rana Ammoury, MD
Recruiting
Medical College of Wisconsin, Children'S of Wisconsin
Milwaukee, Wisconsin, United States
Joshua Noe, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Jul 2023
Primary completion: 31 Mar 2027
Completion: 31 Mar 2027
Last update posted: 5 May 2026
Registered enrollment: 180
Registry id: NCT05660746

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.